Skip to content

Rani Therapeutics Holdings, Inc.

RANI· NasdaqCore metricsCIK 1856725

Pharmaceutical preparations552 peers

Last sale
Nov 6, 2026 · +5.24%
Market cap
$75.56M
139.46M shares
Filings
384
$1.71M
Q3 2026+58.9% FY25 yoy
-$7.73M
Q3 2026N/M FY25 yoy
-$9.22M
Q3 2026N/M FY25 yoy
-$23.51M
Q3 2026derivedN/M FY25 yoy
-$0.04
Q3 2026N/M FY25 yoy
$3.62M
Q3 2026+394.9% FY25 yoy
$75.56M
—
11.5×
2.2×
-30.73%
—

Twelve months to Sep 30, 2026 · derived

Price

$0.541878.33%$1.9582past year
Nov 6, 2026 · IEX last sale
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Revenue

$1.63MFY 2025
$2.72M0FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
PeriodEndedValueKindSource trail
FY 20252025-12-31$1,633,000reported
FY 20242024-12-31$1,028,000reported
FY 20232023-12-31$0reported
FY 20222022-12-31$0reported
FY 20212021-12-31$2,717,000reported
FY 20202020-12-31$462,000reported

Pharmaceutical preparations

Rani Therapeutics Holdings, Inc. is the 205th largest of the 553 covered companies the SEC files under this code, by revenue. SIC 2834

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

Rani Therapeutics Holdings, Inc. · CIK 1856725 · Engraved from SEC EDGAR